LabConnect Appoints Bill Finger to Lead Global Strategic Services

LabConnect has appointed Bill Finger as Senior Vice President of Global Strategic Services, effective September 10, 2025. Finger brings more than 25 years of diagnostics and clinical research experience to the role, with deep expertise in the global lab and pharmacy industry. Recognized as an innovative thinker, he has demonstrated proven ability to develop strategy, drive execution, and advance organizational performance while maintaining focus on operational excellence.

Most recently, Finger served as Vice President and General Manager of Pharma Services with Quest Diagnostics. His previous leadership roles include Chief Operating Officer for Interpace Pharma Solutions, Executive Vice President of Precision Medicine and Pharma for Cancer Genetics, and various leadership positions in scientific affairs and biorepository with LabCorp. This extensive background positions him to effectively lead LabConnect's Scientific Services, Consulting Services, Data Management, and Functional Service Provider teams.

Wes Wheeler, LabConnect CEO, emphasized the significance of this appointment, stating that Finger's leadership in diagnostic and clinical research represents a tremendous asset to the company. His experience is expected to ensure continued anticipation of client needs, delivery of innovative solutions, and reinforcement of LabConnect's commitment to operational excellence for clients worldwide. For more information about LabConnect's services, visit https://www.LabConnect.com.

The appointment comes at a critical time for the clinical research industry, particularly for complex studies involving immuno-oncology, cell and gene therapies, and rare diseases. Finger's expertise in precision medicine and pharmaceutical services aligns with LabConnect's focus on providing comprehensive central laboratory services for analytically and logistically challenging clinical trials. His leadership is anticipated to strengthen the company's position in supporting drug development companies with specialized testing expertise and advanced technological solutions.